Key result
Adiponectin levels were significantly lower among Black and Hispanic participants compared to White participants, and were inversely associated with multiple vascular risk factors.
Cross-Sectional (n=2,900)
No
Effect estimate: Beta -0.203 (Black vs White)
p-value: p=<0.0001
Serum adiponectin levels are lower in blacks and Hispanics compared to whites, and are inversely associated with multiple vascular risk factors, with obesity showing a stronger inverse association in blacks.
Ethnic adiponectin differences may inform vascular risk models in diverse populations; hypothesis-generating and should not yet change practice.
BACKGROUND: Population-based data on serum adiponectin levels, an adipocytokine secreted from adipose tissue, are lacking, particularly across race-ethnic groups. Studies have suggested an inverse association between adiponectin and vascular risk factors, but data are limited and inconsistent. We examined the cross-sectional association between adiponectin, vascular risk factors and race-ethnicity in the population-based Northern Manhattan Study (NOMAS). METHODS: Blood samples, anthropomorphics, and vascular risk factors were collected at baseline. Multivariable linear regression analysis was conducted with log-transformed adiponectin as the dependent variable. RESULTS: Adiponectin was measured among 2900 participants (age 69±10 years, body mass index (BMI) 28.0±5.6, 37% male, 21% white, 53% Hispanic, 24% black). The mean adiponectin was 11.4±6.2 μg/mL (median=9.8, range=2.1-53.3). After multivariable adjustment, adiponectin levels were greatest among whites, followed by Hispanics, and lowest among blacks. Lower adiponectin levels were observed in participants with the following characteristics: Male, former smoking, hypertension, diabetes, homeostasis model assessment of insulin resistance (HOMA-IR), metabolic syndrome, moderate alcohol use, elevated waist circumference, BMI, estimated glomerular filtration rate (eGFR), triglycerides, low-density lipoprotein cholesterol (LDL-C), lower high-density lipoprotein cholesterol (HDL-C), and younger age. Obesity was a stronger risk factor for decreased adiponectin among blacks than among whites or Hispanics. The associations for several vascular risk factors, including hypertension, triglycerides, and low HDL-C, with low adiponectin were stronger among individuals who were not obese than among those who were obese. CONCLUSIONS: Adiponectin levels were lower among blacks and Hispanics and among those with various vascular risk factors, and greater with older age. The association between BMI and adiponectin varied across race-ethnic groups. Investigation of whether differences in body fat distribution may explain race-ethnic differences in adiponectin is needed.
No takes yet. Share an insight, caveat, or question.
Gardener et al. (2012) conducted a cross-sectional in Vascular Risk Factors (n=2,900). Race-ethnicity and vascular risk factors vs. White race and absence of risk factors was evaluated on Log-transformed serum adiponectin levels (Beta -0.203 (Black vs White), p=<0.0001). Adiponectin levels were significantly lower among Black and Hispanic participants compared to White participants, and were inversely associated with multiple vascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: